Suliana Mesquita Paula

Suliana Mesquita Paula

Auto-generated profile, based on publicly available information

Suliana Mesquita Paula

Federal University of Ceará

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2020 in Clinical Science
Verified
Journal Article
Open access
PDF file
MFMilene Tavares Fontes
Milene Tavares Fontes
SPSuliana Mesquita Paula
Suliana Mesquita Paula
CLCaroline Antunes Lino
Caroline Antunes Lino
NSNathalia Senger
Nathalia Senger
GCGisele Kruger Couto
Gisele Kruger Couto
LRLuciana Venturini Rossoni
Luciana Venturini Rossoni
Perivascular adipose tissue (PVAT) dysfunction is associated with vascular damage in cardiometabolic diseases. Although heart failure (HF)-induced endothelial dysfunction is associated with renin–angiotensin system (RAS) activation, no data have correlated this syndrome with PVAT dysfunction. Thus, the aim of the present study was to investigate whether the hyperactivation of the RAS in PVAT participates in the vascular dysfunction observed in rats with HF after myocardial infarction surgery. Wire myograph studies were carried out in thoracic aorta rings in the presence and absence of PVAT. An anticontractile effect of PVAT was observed in the rings of the control rats in the presence (33%) or absence (11%) of endothelium. Moreover, this response was substantially reduced in animals with HF (5%), and acute type 1 angiotensin II receptor (AT1R) and type 2 angiotensin II receptor (AT2R) blockade restored the anticontractile effect of PVAT. In addition, the angiotensin-converting enzyme 1 (ACE1) activity (26%) and angiotensin II levels (51%), as well as the AT1R and AT2R gene expression, were enhanced in the PVAT of rats with HF. Associated with these alterations, HF-induced lower nitric oxide bioavailability, oxidative stress and whitening of the PVAT, which suggests changes in the secretory function of this tissue. The ACE1/angiotensin II/AT1R and AT2R axes are involved in thoracic aorta PVAT dysfunction in rats with HF. These results suggest PVAT as a target in the pathophysiology of vascular dysfunction in HF and provide new perspectives for the treatment of this syndrome.

8 March 2022 in The Laryngoscope
Verified
Journal Article
Closed access
TSThiago Meneses Araújo Leite Sales
Thiago Meneses Araújo Leite Sales
RNRenata Rocha Do Nascimento
Renata Rocha Do Nascimento
JNJoão Pedro Do Carmo Neto
João Pedro Do Carmo Neto
HFHumberto Barbosa da Costa Filho
Humberto Barbosa da Costa Filho
SPSuliana Mesquita Paula
Suliana Mesquita Paula
MSMarcellus Henrique Loiola Ponte de Souza
Marcellus Henrique Loiola Ponte de Souza

1 February 2021 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
JBJavier Blanco-Rivero
Javier Blanco-Rivero
GCGisele Kruger Couto
Gisele Kruger Couto
SPSuliana Mesquita Paula
Suliana Mesquita Paula
MFMilene Tavares Fontes
Milene Tavares Fontes
LRLuciana Venturini Rossoni
Luciana Venturini Rossoni
This study reinforces the pivotal role of noradrenergic innervation in the regulation of mesenteric vascular tone in a rat model of heart failure. Moreover, our results highlight the counteracting role of ATP and NA reuptake, and help to understand the signaling pathways involved on the control of vascular tonus and resistance in heart failure postmyocardial infarction.

31 October 2025 in Intestinal Research
Verified
Journal Article
Open access
PDF file
HFHumberto Barbosa da Costa Filho
Humberto Barbosa da Costa Filho
GAGerardo Autran Cavalcante Araújo
Gerardo Autran Cavalcante Araújo
TSThiago Meneses Araújo Leite Sales
Thiago Meneses Araújo Leite Sales
SPSuliana Mesquita Paula
Suliana Mesquita Paula
MCMarco Antonio de Freitas Clementino
Marco Antonio de Freitas Clementino
MSMarcellus Henrique Loiola Ponte Souza
Marcellus Henrique Loiola Ponte Souza
Background/Aims: Inflammatory bowel disease can be triggered by disturbances in intestinal mucosal integrity, leading to bacterial transmigration. The treatment of inflammatory bowel diseases must not only aim to reduce inflammation, but also to reverse the damage to mucosal barrier function. Janus kinase (JAK) inhibitors have been used to treat inflammatory diseases, including ulcerative colitis. However, little is known about the ability of this class of drugs to reverse the loss of mucosal integrity. This study evaluated the effects of tofacitinib, a JAK pathway inhibitor, on inflammation and colonic mucosal integrity in a rat model of 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis. Methods: Colitis was induced in Wistar rats via rectal administration of TNBS (20 mg+50% ethanol). The control group received only saline. The animals were pretreated with tofacitinib (15 mg/kg) or saline 30 minutes before induction and twice daily thereafter. Seven days after induction, the animals were euthanized, the colon was removed, and myeloperoxidase activity, baseline transepithelial electrical resistance (TER), TER after 1 hour, and fluorescein permeability were assessed. Tight junction proteins in the colon (claudin-2, claudin-15, and tricellulin) were detected using Western blotting. Results: Tofacitinib treatment significantly reduced (P< 0.05) the inflammatory parameters and preserved the integrity of the intestinal epithelial barrier compared with the colitis group (P< 0.05), increased baseline TER, reduced the drop in TER after 1 hour, and decreased paracellular permeability to fluorescein by reducing claudin-2 and claudin-15 expression. Conclusions: JAK inhibition by tofacitinib restored colonic barrier function through antiinflammatory effects and decreased claudin-2 and claudin-15 expressions.

1 January 2023 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
PDF file
HCH.B. Costa-Filho
H.B. Costa-Filho
TST.M.A.L. Sales
T.M.A.L. Sales
SPS.M. Paula
S.M. Paula
LNLucas Antônio Duarte Nicolau
Lucas Antônio Duarte Nicolau
MQM.L. Queiroga
M.L. Queiroga
MSM.H.L.P. Souza
M.H.L.P. Souza
The role of cyclooxygenase (COXs) isoforms in maintaining colonic mucosal integrity is not fully understood. This study aimed to evaluate the role of COX-1 and -2 on colonic mucosal integrity in an experimental colitis model. Colitis was induced in Wistar rats by intracolonic administration of 2,4,6-trinitrobenzenesulfonic acid (20 mg + 50% ethanol). The control group (sham group) received saline only. After 7, 14, or 28 days, colonic samples were removed, and macroscopic lesion scores, wet weight, myeloperoxidase activity, and transepithelial electrical resistance (TER) were determined. In other rat groups, colonic samples from the sham group and a 7th day post-colitis group were mounted in Üssing chambers with the luminal side exposed to a buffer solution (control), acetylsalicylic acid (ASA), SC-560 (COX-1 inhibitor), or celecoxib (COX-2 inhibitor). TER and epithelial permeability to fluorescein were measured. The 7th day colitis group had higher macroscopic damage scores, wet weight, and myeloperoxidase activity and lower basal TER than the sham, 14th day colitis, and 28th day colitis groups. Inhibition of COX-1 but not COX-2 significantly decreased TER and increased permeability to fluorescein in the 7th day post-colitis group compared to the sham group. Additionally, ASA decreased the colonic mucosal integrity on day seven post-colitis compared to the sham group. A decrease in the colonic mucosa integrity in the experimental colitis model can be aggravated only by the inhibition of COX-1, which demonstrated the importance of this enzyme in the maintenance of colonic mucosal integrity.

1 October 2021 in European Journal of Pharmacology
Verified
Journal Article
Closed access
DODaniel Maia Nogueira de Oliveira
Daniel Maia Nogueira de Oliveira
COCarlos Alberto Oliveira-Silva
Carlos Alberto Oliveira-Silva
CPCamila Gadelha Pinheiro
Camila Gadelha Pinheiro
ECEmanuella Feitosa de Carvalho
Emanuella Feitosa de Carvalho
KGKalinne Kelly Lima Gadelha
Kalinne Kelly Lima Gadelha
PMPedro Jorge Caldas Magalhães
Pedro Jorge Caldas Magalhães